Fixed combination therapies in COPD – effect on quality of life

References

• BalterMSLa ForgeJLowDE2003Canadian guidelines for the management of acute exacerbations of chronic bronchitisCan Respir J10Suppl B3B32B
   PubMedGoogle Scholar
• BoschettoPQuintavalleSMiottoD2006Chronic obstructive pulmonary disease (COPD) and occupational exposuresJ Occup Med Toxicol11116756686
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliB2007Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med3567758917314337
   PubMed Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZ2003bMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J229129
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJ2003aCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet36144956
   PubMed Web of Science ®Google Scholar
• CalverleyPWalkerP2003Chronic obstructive pulmonary diseaseLancet36210536114522537
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJM2004The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med35010051214999112
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeW2004Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J239324615219010
   PubMed Web of Science ®Google Scholar
• FabbriLCaramoriGBegheB1998Chronic obstructive pulmonary disease international guidelinesCurr Opin Pulm Med476849612669
   PubMedGoogle Scholar
• FletcherCPetoR1977The natural history of chronic airflow obstructionBMJ116458871704
   PubMed Web of Science ®Google Scholar
• Groneberg-KloftBKrausTvan MarkA2006Analysing the causes of chronic cough: Relation to diesel exhaust, ozone, nitrogen oxides, sulphur oxides and other environmental factorsJ Occup Med Toxicol1616722555
   PubMed Web of Science ®Google Scholar
• HajiroTNishimuraKTsukinoM1998Comparison of discriminative properties among disease-specific questionnaires for measuring health related quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med157785909517591
   PubMed Web of Science ®Google Scholar
• HananiaNADarkenPHorstmanD2003The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest1248344312970006
   PubMed Web of Science ®Google Scholar
• Hansen-FlaschenJH2003Update in pulmonary medicineAnn Intern Med1383192512585830
   PubMedGoogle Scholar
• JonesPWQuirkFHBaveystockCMLittlejohnsP1992A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory QuestionnaireAm Rev Respir Dis145132171595997
   PubMed Web of Science ®Google Scholar
• KetelaarsCAJSchlosserMAGMostertR1996Determinants of health-related quality of life in patients with chronic obstructive pulmonary diseaseThorax5139438658367
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanD2002Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16610849112379552
   PubMed Web of Science ®Google Scholar
• McSweenyAJGrantIHeatonRK1982Life quality of patients with chronic obstructive pulmonary diseaseArch Intern Med14247387065785
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997aAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet3491498504
   PubMed Web of Science ®Google Scholar
• MurrayCJLLopezAD1997bGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease StudyLancet349143642
   PubMed Web of Science ®Google Scholar
• MurrayCJLLopezAD1997cMortality by cause for eight regions of the world: Global Burden of Disease StudyLancet349126976
   PubMed Web of Science ®Google Scholar
• MurrayCJLLopezADMathersCDSteinC2001The Global Burden of Disease 2000 Project: global programme on evidence for health policy discussionGenevaWHO, paper number 36.
   Google Scholar
• NanniniLCatesCJLassersonTJPooleP2004Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary diseaseCochrane Database Syst RevCD00379415266502
   PubMedGoogle Scholar
• National Heart LaBI2002NHLBI morbidity and mortality chartbookBethesdaUS Department of Health and Human Services, Public Health Service
   Google Scholar
• PauwelsRABuistASCalverleyPM2001Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med16312567611316667
   PubMedGoogle Scholar
• PetoRSpeizerFECochraneAL1983The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observationAm Rev Respir Dis1284915006614643
   PubMed Web of Science ®Google Scholar
• RennardSDecramerMCalverleyPM2002Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International SurveyEur Respir J2079980512412667
   PubMed Web of Science ®Google Scholar
• SiafakasNMVermeirePPrideNB1995Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEur Respir J813984207489808
   PubMed Web of Science ®Google Scholar
• SocietyAT1987Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986Am Rev Respir Dis136225443605835
   PubMed Web of Science ®Google Scholar
• SorianoJBMaierWCEggerP2000Recent trends in physician diagnosed COPD in women and men in the UKThorax557899410950900
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezA2003Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J21748112570112
   PubMed Web of Science ®Google Scholar
• WelteTGronebergDA2006Asthma and COPDExp Toxicol Pathol57S23540
   Google Scholar
• WoutersEFPostmaDSFokkensB2005Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trialThorax60480715923248
   PubMed Web of Science ®Google Scholar